Cosmetic Outcome and Quality of Life of Patients Undergoing Once Weekly Hypofractionated Breast Irradiation (WHBI): Interim Analysis of an Institutional Phase II Trial

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2015.07.549
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Second Conservative Treatment for Breast Cancer Local Recurrence Using HDR Interstitial Brachytherapy: Cosmetic Outcome and Quality of Life

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Recommendations for Hypofractionated Whole-Breast Irradiation

Revista da Associacao Medica Brasileira
Medicine
2018English

Vertebral Fracture Risk After Once-Weekly Teriparatide Injections: Follow-Up Study of Teriparatide Once-Weekly Efficacy Research (TOWER) Trial

Current Medical Research and Opinion
Medicine
2013English

Improved Treatment Satisfaction and Weight-Related Quality of Life With Exenatide Once Weekly or Twice Daily

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Determinants of Quality of Life in Patients With Breast Cancer Undergoing External Beam Radiotherapy

Archives of Medical Science
Medicine
2015English

A Phase II Study of Once a Day Partial Breast Irradiation (PBI) for Early-Stage or Noninvasive Breast Cancer: Early Toxicity Outcomes

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology
Urology
2008English

Multicenter Phase II Study With Weekly Bendamustine and Paclitaxel as First- Or Later-Line Therapy in Patients With Metastatic Breast Cancer: RiTa II Trial

Breast Care
SurgeryOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy